Eyüpoğlu, Nesrin Damla, Olgu Erkin Çınar, Salih Aksu, Yahya Büyükaşık, Nilgün Sayınalp, Haluk Demiroğlu, Hakan Göker, Osman İlhami Özcebe, and İbrahim C. Haznedaroğlu. “Event-Free Survival in Patients With Chronic Myeloid Leukemia Receiving Front-Line Imatinib Mesylate”. Acta Medica 53, no. 3 (June 15, 2022): 277–283. Accessed April 19, 2024. https://actamedica.org/index.php/actamedica/article/view/745.